申请人:UNIVERSITE DE GENEVE
公开号:EP1698357A1
公开(公告)日:2006-09-06
Compounds having phosphonic acid groups or a derivative thereof, corresponding to the general formula (I)
A-[P(O)(OH)2]p (I),
or a pharmaceutically acceptable derivative thereof, wherein A means a residue of a linear, branched or cyclic, saturated or unsaturated, hydrocarbon residue with n carbon atoms, whereby said residue may be substituted by hydroxyl and/or carboxyl and optionally further interrupted by one or more oxygen and/or sulphur and/or nitrogen atoms, carrying p phosphonic acid groups, wherein n is a number from 4 to 70, and p is 3, 4, 5 or 6, are especially suitable to treat surfaces of Endosseous implants to be applied to a human or animal bone to improve osseointegration.
具有与通式(I)相对应的膦酸基团或其衍生物的化合物
A-[P(O)(OH)2]p (I)、
或其药学上可接受的衍生物,其中 A 指具有 n 个碳原子的线性、支链或环状、饱和或不饱和烃残基,所述残基可被羟基和/或羧基取代,并可选择进一步被一个或多个氧和/或硫和/或氮原子打断、含有 p 个膦酸基团,其中 n 为 4 至 70 之间的数字,p 为 3、4、5 或 6,特别适用于处理应用于人类或动物骨骼的骨内植体表面,以改善骨结合。